Get Adobe Flash player
Start Products SPECIAL Hip Revision BioBall® MaxiMotion™ Cup


BioBall® MaxiMotion™ Cup -

Our modular solution for maximum joint stability

Dislocation is one of the most common complications following primary or revision arthroplasty. Dual-mobility implants improve prosthetic stability and increase range of motion substantially.

Now, the proven BioBall® system can finally be combined with the Dual Mobility concept.

The result? A great deal of intra-operative flexibility (neck length/offset) plus minimal dislocation risk to give your patients maximum mobility support.


Why choose BioBall® MaxiMotion™?

    • Increased range of motion (ROM) in combination with BioBall® options, thus effectively lowering dislocation risks
    • Being able to combine with the proven BioBall® adapter system allows surgeons to adjust to the patient‘s individual situation during the pre- and intraoperative stages (neck lengths up to 5XL; offset settings)
    • Inlay and BioBall® head are already pre-assembled, eliminating the need to press them together on site. The BioBall® adapter system helps determine the neck length/offset needed, reducing the number of instruments required for trial inserts
    • Wear rates tested and confirmed in an accredited testing laboratory (ISO 14242-1:2012)
    • MaxiMotion™ Cup can be combined with BioBall® standard and offset adapters in all available sizes



Design features:

      • Metal hip cup, PE-Inlay, Ø28 mm metal head or BIOLOX® delta1 ceramic head plus BioBall® adapter
      • Cemented and non-cemented versions
      • MaxiMotion™ Cup available with pre-assembled metal or ceramic head
      • Materials: Vivium / UHMWPE / DELTA ceramic head or Vivium™ / titanium alloy TiAl6V4 ELI (ISO 5832-3)



      • High dislocation risk
      • Advanced wear of the hip joint secondary to the degenerative and rheumatic diseases or post-traumatic disorders, including advanced avascular head necrosis, which cannot be treated conservatively or by using joint-sparing surgical techniques.
      • The sequelae of previous surgeries (failure of total hip arthroplasty, failure of hemiarthroplasty or osteosynthesis of fractures localised in the proximity of the femoral head and osteotomies in the proximity of hip joint).



    • Acute or chronic infections in the hip joint or the immediate vicinity
    • Patients with joint diseases that may be successfully treated with another, joint-preserving treatment
    • Insufficient implant bed, which precludes its secure anchoring (e.g. insufficient bone quality, which impairs the bone or large acetabular defects).
    • Any comorbid conditions which could compromise the implant’s functionality or hinder its success, in particular severe disorders of the muscles, nerves or blood vessels, posing a risk to the affected extremities